Literature DB >> 26255853

Formation and characterisation of neuromuscular junctions between hiPSC derived motoneurons and myotubes.

M Demestre1, M Orth2, K J Föhr3, K Achberger4, A C Ludolph2, S Liebau4, T M Boeckers5.   

Abstract

Striated skeletal muscle cells from humans represent a valuable source for in vitro studies of the motoric system as well as for pathophysiological investigations in the clinical settings. Myoblasts can readily be grown from human muscle tissue. However, if muscle tissue is unavailable, myogenic cells can be generated from human induced pluripotent stem cells (hiPSCs) preferably without genetic engineering. Our study aimed to optimize the generation of hiPSCs derived myogenic cells by employing selection of CD34 positive cells and followed by distinct, stepwise culture conditions. Following the expansion of CD34 positive single cells under myogenic cell culture conditions, serum deprived myoblast-like cells finally fused and formed multinucleated striated myotubes that expressed a set of key markers for muscle differentiation. In addition, these myotubes contracted upon electrical stimulation, responded to acetylcholine (Ach) and were able to generate action potentials. Finally, we co-cultured motoneurons and myotubes generated from identical hiPSCs cell lines. We could observe the early aggregation of acetylcholine receptors in muscle cells of immature co-cultures. At later stages, we identified and characterised mature neuromuscular junctions (NMJs). In summary, we describe here the successful generation of an iPS cell derived functional cellular system consisting of two distinct communicating cells types. This in vitro co-culture system could therefore contribute to research on diseases in which the motoneurons and the NMJ are predominantly affected, such as in amyotrophic lateral sclerosis or spinal muscular atrophy.
Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acetylcholine receptor; Amyotrophic lateral sclerosis; Human induced pluripotent stem cells; Motoneuron; Motoneuron diseases; Myotubes; Neuromuscular junction

Mesh:

Substances:

Year:  2015        PMID: 26255853     DOI: 10.1016/j.scr.2015.07.005

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  41 in total

1.  Bioinspired Three-Dimensional Human Neuromuscular Junction Development in Suspended Hydrogel Arrays.

Authors:  Thomas Anthony Dixon; Eliad Cohen; Dana M Cairns; Maria Rodriguez; Juanita Mathews; Rod R Jose; David L Kaplan
Journal:  Tissue Eng Part C Methods       Date:  2018-06       Impact factor: 3.056

2.  Influencing Early Stages of Neuromuscular Junction Formation through Glycocalyx Engineering.

Authors:  Mia L Huang; Ember M Tota; Taryn M Lucas; Kamil Godula
Journal:  ACS Chem Neurosci       Date:  2018-08-28       Impact factor: 4.418

3.  A Human-Based Functional NMJ System for Personalized ALS Modeling and Drug Testing.

Authors:  Xiufang Guo; Virginia Smith; Max Jackson; My Tran; Michael Thomas; Aakash Patel; Eric Lorusso; Siddharth Nimbalkar; Yunqing Cai; Christopher W McAleer; Ying Wang; Christopher J Long; James J Hickman
Journal:  Adv Ther (Weinh)       Date:  2020-08-11

4.  Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro.

Authors:  Jérome Chal; Ziad Al Tanoury; Marie Hestin; Bénédicte Gobert; Suvi Aivio; Aurore Hick; Thomas Cherrier; Alexander P Nesmith; Kevin K Parker; Olivier Pourquié
Journal:  Nat Protoc       Date:  2016-09-01       Impact factor: 13.491

Review 5.  In vitro models of neuromuscular junctions and their potential for novel drug discovery and development.

Authors:  Olaia F Vila; Yihuai Qu; Gordana Vunjak-Novakovic
Journal:  Expert Opin Drug Discov       Date:  2019-12-17       Impact factor: 6.098

6.  Bioreactor model of neuromuscular junction with electrical stimulation for pharmacological potency testing.

Authors:  Surapon N Charoensook; Damian J Williams; Syandan Chakraborty; Kam W Leong; Gordana Vunjak-Novakovic
Journal:  Integr Biol (Camb)       Date:  2017-12-11       Impact factor: 2.192

7.  iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases.

Authors:  Chuang-Yu Lin; Michiko Yoshida; Li-Tzu Li; Akihiro Ikenaka; Shiori Oshima; Kazuhiro Nakagawa; Hidetoshi Sakurai; Eriko Matsui; Tatsutoshi Nakahata; Megumu K Saito
Journal:  JCI Insight       Date:  2019-09-19

Review 8.  Engineered skeletal muscles for disease modeling and drug discovery.

Authors:  Jason Wang; Alastair Khodabukus; Lingjun Rao; Keith Vandusen; Nadia Abutaleb; Nenad Bursac
Journal:  Biomaterials       Date:  2019-08-08       Impact factor: 12.479

9.  Stem cell derived phenotypic human neuromuscular junction model for dose response evaluation of therapeutics.

Authors:  Navaneetha Santhanam; Lee Kumanchik; Xiufang Guo; Frank Sommerhage; Yunqing Cai; Max Jackson; Candace Martin; George Saad; Christopher W McAleer; Ying Wang; Andrea Lavado; Christopher J Long; James J Hickman
Journal:  Biomaterials       Date:  2018-02-27       Impact factor: 12.479

Review 10.  Multi-lineage Human iPSC-Derived Platforms for Disease Modeling and Drug Discovery.

Authors:  Arun Sharma; Samuel Sances; Michael J Workman; Clive N Svendsen
Journal:  Cell Stem Cell       Date:  2020-03-05       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.